These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11206960)

  • 1. Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease.
    Brittenham GM; Sheth S; Allen CJ; Farrell DE
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):37-56. PubMed ID: 11206960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
    Stanley HM; Friedman DF; Webb J; Kwiatkowski JL
    Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How we manage iron overload in sickle cell patients.
    Coates TD; Wood JC
    Br J Haematol; 2017 Jun; 177(5):703-716. PubMed ID: 28295188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients.
    Canavese C; Bergamo D; Ciccone G; Longo F; Fop F; Thea A; Martina G; Piga A
    Kidney Int; 2004 Mar; 65(3):1091-8. PubMed ID: 14871430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Iron Overload in Sickle Cell Disease: A Rare But Potentially Fatal Complication of Transfusion.
    Tavares AHJ; Benites BD; Fertrin KY
    Transfus Med Rev; 2019 Jul; 33(3):170-175. PubMed ID: 31153715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of liver iron concentration by superconducting quantum interference device biomagnetic liver susceptometry validates serum ferritin as prognostic parameter for allogeneic stem cell transplantation.
    Jacobi N; Herich L
    Eur J Haematol; 2016 Oct; 97(4):336-41. PubMed ID: 26800433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences and management of iron overload in sickle cell disease.
    Porter J; Garbowski M
    Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
    Tsitsikas DA; Nzouakou R; Ameen V; Sirigireddy B; Amos RJ
    Eur J Haematol; 2014 Feb; 92(2):164-7. PubMed ID: 24175986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.
    Ballas SK
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):30-6. PubMed ID: 11206959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal iron load in sickle cell disease is influenced by severity of haemolysis.
    Vasavda N; Gutiérrez L; House MJ; Drašar E; St Pierre TG; Thein SL
    Br J Haematol; 2012 Jun; 157(5):599-605. PubMed ID: 22409346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive measurement of iron: report of an NIDDK workshop.
    Brittenham GM; Badman DG;
    Blood; 2003 Jan; 101(1):15-9. PubMed ID: 12393526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum ferritin and total units transfused for assessing iron overload in adults with sickle cell disease.
    Drasar E; Vasavda N; Igbineweka N; Awogbade M; Allman M; Thein SL
    Br J Haematol; 2012 Jun; 157(5):645-7. PubMed ID: 22332939
    [No Abstract]   [Full Text] [Related]  

  • 15. Post-transfusional iron overload in the haemoglobinopathies.
    Thuret I
    C R Biol; 2013 Mar; 336(3):164-72. PubMed ID: 23643400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac iron across different transfusion-dependent diseases.
    Wood JC
    Blood Rev; 2008 Dec; 22 Suppl 2(Suppl 2):S14-21. PubMed ID: 19059052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathophysiology of transfusional iron overload.
    Porter JB; Garbowski M
    Hematol Oncol Clin North Am; 2014 Aug; 28(4):683-701, vi. PubMed ID: 25064708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
    Wilson SR; Sears M; Williams E; Drapekin J; Sivakumar I; Padrino S; Desai PC; Hager W; Manwani D; Clay LJ; Field JJ; Kanter J; Cohen AJ; Saif Ur Rehman S; Lanzkron S; Little JA;
    Br J Haematol; 2021 Dec; 195(5):e157-e160. PubMed ID: 34423416
    [No Abstract]   [Full Text] [Related]  

  • 19. [Iron overload in sickle cell anemia : a study of 94 patients].
    Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
    Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.